COMMUNIQUÉS West-GlobeNewswire

-
ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
17/04/2024 -
Hospice Choices: VITAS® Healthcare Opens in Alabama, Expands in Florida Panhandle
17/04/2024 -
River Oaks Treatment Center is Setting the Standard for Clinical Excellence in Florida with Four Board-Certified Addiction Medicine Physicians
17/04/2024 -
Ipsen publishes its 2023 Universal Registration Document
17/04/2024 -
Ipsen publie son Document d’enregistrement universel 2023
17/04/2024 -
AAMI Releases Guidance on Dilator, Ultrasound DeSterilization
17/04/2024 -
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
17/04/2024 -
Change in Leadership at AFB’s Journal of Visual Impairment & Blindness as Longtime Editor in Chief Sandra Lewis Steps Down, Robert Wall Emerson of Western Michigan University to Fill the Role
17/04/2024 -
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
17/04/2024 -
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
17/04/2024 -
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
17/04/2024 -
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
17/04/2024 -
Unlocking the Secrets to a Sharper Mind and Healthier Cells
17/04/2024 -
Mobile-health Network Solutions Ranked Number 41 in Financial Times Listing of 500 High-growth Asia-Pacific Companies
17/04/2024 -
IGM Biosciences Announces Refocusing of Sanofi Collaboration
17/04/2024 -
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
17/04/2024 -
Cerevance Presents at 35th Symposium on Medicinal Chemistry in Eastern England
17/04/2024 -
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
17/04/2024 -
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
17/04/2024
Pages